92 related articles for article (PubMed ID: 27411269)
1. [PROMOTION EFFECT OF FTY-720P ON TREATMENT OF BONE DEFECT WITH ALLOGRAFT BONE BY SUPPRESSING OSTEOCLAST FORMATION AND FUNCTION].
Huang Y; Huang D; Zhang D; Mou Y; Liu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Apr; 30(4):426-31. PubMed ID: 27411269
[TBL] [Abstract][Full Text] [Related]
2. FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2).
Zhang D; Huang Y; Huang Z; Zhang R; Wang H; Huang D
Med Sci Monit; 2016 Jun; 22():2187-94. PubMed ID: 27344392
[TBL] [Abstract][Full Text] [Related]
3. [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism].
Zeng L; Xu Y; Xing G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):568-574. PubMed ID: 29806344
[TBL] [Abstract][Full Text] [Related]
4. [Effects of M-CSF concentration, RANKL concentration and M-CSF preinduction on osteoclastogenesis].
Dong W; Yu J; Qi M; Bai Y; Liang R; Chen H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1336-40. PubMed ID: 21374990
[TBL] [Abstract][Full Text] [Related]
5. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
[TBL] [Abstract][Full Text] [Related]
6. The sphingosine-1-phosphate receptor 1 binding molecule FTY720 inhibits osteoclast formation in rats with ligature-induced periodontitis.
Lee DE; Kim JH; Choi SH; Cha JH; Bak EJ; Yoo YJ
J Periodontal Res; 2017 Feb; 52(1):33-41. PubMed ID: 26932498
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
8. [The effect of ferric ion on the differentiation of osteoclast and bone resorption].
Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
[TBL] [Abstract][Full Text] [Related]
10. [EFFECT OF STAPHYLO CO CCAL PEPTID O GLYCAN ON OSTEO CL AST DIFFERENTIATION].
Ren L; Xu Y; Wang H; He X; Song M; Chen X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Aug; 30(8):1006-1010. PubMed ID: 29786233
[TBL] [Abstract][Full Text] [Related]
11. [Effects of rat serum containing Chinese herbal medicine Sangen Decoction on osteoclastogenesis and bone resorption of osteoclasts induced by polymethylmethacrylate particles].
Wang SQ; Rao W; Deng LF; Zhu YP; Chen YQ
Zhong Xi Yi Jie He Xue Bao; 2011 Jan; 9(1):64-9. PubMed ID: 21227035
[TBL] [Abstract][Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
14. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
16. Effects of 10-hydroxycamptothecin on differentiation of RAW264.7 cells into osteoclasts.
Zhang M; Wang Y; Sun XL; Ren LL; Zhang LJ; Lu HQ
J Biol Regul Homeost Agents; 2016; 30(3):789-794. PubMed ID: 27655499
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.
Herrera BS; Bastos AS; Coimbra LS; Teixeira SA; Rossa C; Van Dyke TE; Muscara MN; Spolidorio LC
J Periodontol; 2014 Apr; 85(4):e72-81. PubMed ID: 24059638
[TBL] [Abstract][Full Text] [Related]
19. Expressions of RANKL/RANK and M-CSF/c-fms in root resorption lacunae in rat molar by heavy orthodontic force.
Nakano Y; Yamaguchi M; Fujita S; Asano M; Saito K; Kasai K
Eur J Orthod; 2011 Aug; 33(4):335-43. PubMed ID: 20833686
[TBL] [Abstract][Full Text] [Related]
20. Effects of pulsed electromagnetic fields on the expression of NFATc1 and CAII in mouse osteoclast-like cells.
He J; Zhang Y; Chen J; Zheng S; Huang H; Dong X
Aging Clin Exp Res; 2015 Feb; 27(1):13-9. PubMed ID: 24869857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
